Cause of death, by non-communicable diseases, ages 0-4 in Azerbaijan
Azerbaijan: Cause of death, by non-communicable diseases, ages 0-4 was 35.1% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4 in Azerbaijan, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 0-4.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 0-4 in Azerbaijan stood at 35.1%. That is the highest value across all 6 years on record.
That represents a change of up 2.0% on the previous year and up 111.7% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4 in Azerbaijan peaked at 35.1% in 2021 and was at its lowest, 11.5%, in 2000.
Azerbaijan ranks 74th of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 0-4 in Azerbaijan, year by year
| Year | % of total deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 11.5% | — |
| 2010 | 16.6% | +44.2% |
| 2015 | 27.3% | +64.8% |
| 2019 | 32.6% | +19.4% |
| 2020 | 34.4% | +5.6% |
| 2021 | 35.1% | +2.0% |
Azerbaijan compared with similar countries
- Azerbaijan's 35.1% is above the median for upper middle income countries, which is 31.9%, 1.1× the median. (55 countries reporting)
- Azerbaijan's 35.1% is below the median for Europe & Central Asia, which is 39.7%, 88% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 11.5% | 11.5% | 11.5% | 1 |
| 2010s | 25.5% | 16.6% | 32.6% | 3 |
| 2020s | 34.8% | 34.4% | 35.1% | 2 |
Countries ranked near Azerbaijan
More health data for Azerbaijan
- Un projection of annual infant deaths, annual growth rate -1.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1127 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,241 deaths per 1,000 people (2090)
- Number of infants who die before age 1 264 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.72 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0286 units per person (2025)
- Population ages 00-04, male, annual growth rate -4.06 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4 in Azerbaijan?
- Cause of death, by non-communicable diseases, ages 0-4 in Azerbaijan was 35.1% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4 recorded in Azerbaijan?
- The highest recorded value was 35.1% in 2021.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4 recorded in Azerbaijan?
- The lowest recorded value was 11.5% in 2000.
- How does Azerbaijan rank for cause of death, by non-communicable diseases, ages 0-4?
- Azerbaijan ranks 74th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4 rising or falling in Azerbaijan?
- Over the last ten years it is up 111.7%. The long-run trend across the full record is rising.
- Where does this Azerbaijan data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.